Regional Biotech Sales Director - Rare Disease Launch

Syneos Health/ inVentiv Health Commercial LLC; Atlanta (GA); In loco; USD 220.000 - 228.000; Tempo pieno

Vantaggi offerti da questo lavoro

Company car or car allowance

Commissions / bonus potential

Descrizione del lavoro

Syneos Health is seeking a Regional Sales Director to lead a high-performing field team and drive commercial success for a rare disease launch. You will recruit, mentor, and develop KAMs, build regional business plans, and establish strong relationships with hospital systems and IDNs.

You'll oversee performance metrics, collaborate with Medical Affairs, Market Access and Marketing to ensure launch readiness and patient access, while delivering sustainable growth across the region.

Competenze

• 10+ years in Life Sciences.
• 4+ years of first-line sales leadership.
• Experience leading rare disease or specialty launches.
• Strong oncology or related therapeutic background.
• Deep understanding of formulary and market access.

Mansioni

• Hire, mentor, coach, and retain a high-performing regional sales team.
• Develop and execute regional business plans to support a launch.
• Build relationships with hospital systems, IDNs, and key influencers.
• Provide clinical, pharmacoeconomic and business presentations to customers.

Conoscenze

Life sciences sales leadership

Hospital/IDN relationships

Launch leadership

Oncology/specialty therapeutics

P&T committee and formulary knowledge

Cross-functional collaboration

Payer and access strategy

Descrizione del lavoro

Syneos Health is seeking a Regional Sales Director to lead a high-performing field team and drive commercial success for a rare disease launch. You will recruit, mentor, and develop KAMs, build regional business plans, and establish strong relationships with hospital systems and IDNs.

You'll oversee performance metrics, collaborate with Medical Affairs, Market Access and Marketing to ensure launch readiness and patient access, while delivering sustainable growth across the region.